Brosius Mark: insider trades.
Brosius Mark reported 14 non-derivative transactions on 6 SEC ownership filings in Q3 2026: 0 open-market purchases and 14 sales ($242K), across 1 company.
- Transactions
- 14
- Purchases (P)
- 0
- Sales (S)
- 14
- Companies
- 1
- Name as filed
- Brosius Mark
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Intuitive Surgical Inc (ISRG) | Officer · EVP & Chief Mfg and Supply Cha | 14 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-11 | Intuitive Surgical Inc | S | 25 | $365.79 | 764 | Form 4 |
| 2026-09-10 | Intuitive Surgical Inc | S | 23 | $347.66 | 789 | Form 4 |
| 2026-09-09 | Intuitive Surgical Inc | S | 23 | $350.2 | 812 | Form 4 |
| 2026-09-08 | Intuitive Surgical Inc | S | 46 | $361.23 | 835 | Form 4 |
| 2026-08-21 | Intuitive Surgical Inc | S | 77 | $375.57 | 881 | Form 4 |
| 2026-08-20 | Intuitive Surgical Inc | S | 77 | $396.37 | 958 | Form 4 |
| 2026-08-19 | Intuitive Surgical Inc | S | 77 | $394.26 | 1,035 | Form 4 |
| 2026-08-18 | Intuitive Surgical Inc | S | 77 | $394 | 1,112 | Form 4 |
| 2026-08-17 | Intuitive Surgical Inc | S | 77 | $390.67 | 1,189 | Form 4 |
| 2026-07-31 | Intuitive Surgical Inc | S | 28 | $351 | 1,266 | Form 4 |
| 2026-07-30 | Intuitive Surgical Inc | S | 28 | $346.83 | 1,294 | Form 4 |
| 2026-07-29 | Intuitive Surgical Inc | S | 28 | $360.21 | 1,322 | Form 4 |
| 2026-07-28 | Intuitive Surgical Inc | S | 28 | $365.58 | 1,350 | Form 4 |
| 2026-07-27 | Intuitive Surgical Inc | S | 28 | $344 | 1,378 | Form 4 |
Questions
What stock did Brosius Mark buy or sell?
Brosius Mark reported 14 non-derivative transactions on 6 SEC ownership filings in Q3 2026: 0 open-market purchases and 14 sales ($242K), across 1 company.
Is Brosius Mark the same person as other filers with this name?
This page covers SEC CIK 2010300 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/brosius-mark-2010300.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.